XML 15 R23.htm IDEA: XBRL DOCUMENT v3.19.3
Overview (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended
Feb. 03, 2020
Nov. 01, 2019
Oct. 01, 2019
Sep. 30, 2019
Mar. 02, 2020
Jan. 02, 2020
Dec. 02, 2019
Nov. 01, 2018
Organization, Consolidation and Presentation of Financial Statements [Line Items]                
Reverse terminantion fee       $ 98.0        
Period in which company must repay continuation advances if change-of-controll transaction is entered into with third party       2 years        
Equity or debt financing that must be raised in a single transaction       $ 100.0        
Possible termination fee       $ 43.0        
Illumina, FC Ops Corp [Member] | Pacific Biosciences of California, Inc. [Member]                
Organization, Consolidation and Presentation of Financial Statements [Line Items]                
Purchase price, per share amount               $ 8.00
Payments due for merger     $ 6.0          
Merger payments made     $ 6.0          
Illumina, FC Ops Corp [Member] | Pacific Biosciences of California, Inc. [Member] | Forecast [Member]                
Organization, Consolidation and Presentation of Financial Statements [Line Items]                
Payments due for merger         $ 6.0 $ 6.0 $ 6.0  
Merger payments made $ 22.0              
Subsequent Event [Member] | Illumina, FC Ops Corp [Member] | Pacific Biosciences of California, Inc. [Member]                
Organization, Consolidation and Presentation of Financial Statements [Line Items]                
Payments due for merger   $ 6.0            
Merger payments made   $ 6.0